With a total funding of $150,000, FSR will support Paul’s research on the role of neutrophils and arginine metabolism in granuloma formation in sarcoidosis. His work aims to uncover novel metabolic targets for therapeutic intervention.
We warmly congratulate Paul on this major achievement!
Link to the official article on FSR